Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative macular degeneration Journal Article uri icon
Overview
abstract

  • PURPOSE: To report a hemorrhagic complication from thrombolytic therapy in a patient with exudative macular degeneration. CASE REPORT: A 75 year old patient with exudative macular degeneration developed pain and loss of vision in the left eye shortly after receiving tissue plasminogen activator (t-PA) for a myocardial infarction. Examination revealed the patient to be in angle closure. A CT scan revealed the etiology of the angle closure to be a dense vitreous hemorrhage pushing the iris-lens diaphragm forward. Intraocular pressure was treated successfully, but the final visual acuity was only light perception. CONCLUSIONS: Thrombolytic therapy can lead to devastating intraocular hemorrhages. The presence of exudative macular degeneration may potentially increase the risk of developing such complications.

    • Link to Article
    authors
    publication date
  • 2003
    • published in
    Research
    keywords
  • Aged
  • Antihypertensive Agents/therapeutic use
  • Exudates and Transudates
  • Eye Hemorrhage/*chemically induced/drug therapy
  • Fibrinolytic Agents/*adverse effects
  • Intraocular Pressure
  • Macular Degeneration/*complications
  • Myocardial Infarction/drug therapy
  • Thrombolytic Therapy/*adverse effects
  • Tissue Plasminogen Activator/*adverse effects
  • Treatment Outcome
  • Visual Acuity
    • Additional Document Info
    volume
  • 13
    • issue
  • 1